Apricitabine: a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor for the treatment of nucleoside-resistant HIV infection.

Wainberg, Mark A; Cahn, Pedro; Bethell, Richard C; Sawyer, James; Cox, Susan

Wainberg, Mark A; Cahn, Pedro; Bethell, Richard C; Sawyer, James; Cox, Susan.

Affiliation

Wainberg MA; McGill University AIDS Center, Lady Davis Institute-Jewish General Hospital, Montreal, Canada.

Antivir Chem Chemother ; 18(2): 61-70, 2007.

Article in En | MEDLINE | ID: mdl-17542150

Subject(s)

Anti-HIV Agents/therapeutic use; Deoxycytidine/analogs & derivatives; HIV Infections/drug therapy; Deoxycytidine/adverse effects; Deoxycytidine/pharmacokinetics; Deoxycytidine/pharmacology; Deoxycytidine/therapeutic use; Drug Resistance, Viral; Humans

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Deoxycytidine Type of study: Clinical_trials Limits: Humans Language: En Journal: Antivir Chem Chemother Journal subject: QUIMICA / TERAPIA POR MEDICAMENTOS / VIROLOGIA Year: 2007 Document type: Article Affiliation country: Canada Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links